To continue with the #SLAS2026 award season announcements, congratulations to SLAS Ignite Award winner, XDemics Corporation. XDemics was chosen for their cell expansion technology, facilitating the scalability of cell production and received $5,000.

Another big award announcement to come out of #SLAS2026 in Boston was the bi-annual New Product Award winners. Congratulations to Beckman Coulter Life Sciences, BioDot and @emulatebio.bsky.social. Learn a bit more about their winning innovations: https://ow.ly/V7UG50YhfW3

Congratulations to the #SLAS2026 Innovation Award winner: Steven Finkbeiner, MD, PhD (Gladstone and the University of California San Francisco) for Development and Application of AI-powered Label-free Imaging for Assays and Screening.

We can't believe the final day of #SLAS2026 is here, but don't worry, we still have a full day of programming left including this morning's Closing Keynote. SLAS Assistant Scientific Director Emily Yamasaki, PhD, gives you a full breakdown of what's coming up today.

Two SLAS Past Presidents. Two Board Directors. One conversation on the future of drug discovery. Join GreinerBioOne at #SLAS2026 NexusXp (Booth 1404). Boston, Feb 9-11!

https://events.rdmobile.com/Sessions/Details/3216128

On the latest episode of New Matter, speakers from each of the participating #SLAS2026 NexusXp Integration Showcase sponsors preview their presentations that will take place in the pavilion and compete for the coveted People's Choice Award: https://www.slas.org/education/new-matter-podcast/.

Join Thermo Fisher & Moderna for their #SLAS2026 NexusXp Integration Scenario Showcase, Mon Feb 9 at 3:00 p.m. in the NexusXp Pavilion, focused on real-world integration strategies for moving automation from discovery to regulated clinical environs: https://ow.ly/yWEX50Y893x

We’re officially one week out from the kickoff of #SLAS2026 and the countdown is on. Advance registration rates are available through Friday, February 6, before onsite rates begin on Saturday. A range of registration options are available: https://ow.ly/bZVf50Y7Kg9.

This Monday is the deadline for the final two #SLASEurope2026 award opportunities designed for students and early-career professionals. Learn more about the SLAS Travel and Student Poster Award: https://www.slas.org/events-calendar/slas-europe-2026-conference-and-exhibition/present/.

We’re excited to join NexusXp at #SLAS2026 for Designing the Future: Collaborative Innovation in DMTA! Hamilton Robotics is leading the way in creating adaptable, data-driven design ecosystems that accelerate discovery.

Feb 10 | 11:00 AM

Learn more: www.hamiltoncompany.com/slas-2026

Innovation AveNEW | SLAS Europe 2026 Conference and Exhibition Start-Ups and emerging companies can gain extra visibility of their company, product and service through this specially designated area of SLAS Europe 2026

Startups: It's the last call to apply for a spot on Innovation AveNEW at #SLASEurope2026. Final applications are due Monday for the opportunity to receive a complimentary kiosk and elevated promotional benefits. View full application and benefit details: https://ow.ly/amke50Y0OE8.

SLAS 2026 Meetings Book a meeting with Ginkgo Bioworks at SLAS 2026.

@ginkgobioworks.bsky.social pioneered the autonomous lab and is building a 97-robot DOE lab for the Genesis Mission. Visit NexusXp to explore self-driving labs, demo AI for closed-loop science, and see a live lab in action at Booth #1823. Book a meeting to learn more. hubs.la/Q03ZV9X90 #SLAS2026

We're excited to announce the 11 companies selected to compete for the #SLAS2026 New Product Award. From cutting-edge instrumentation to smart automation platforms, these innovations are set to transform how science is done: https://ow.ly/85WY50XZnVJ.

Precision pain management meets green nanotech. A folic acid–targeted magnetic nanoparticle transdermal system delivered effective, low-toxicity tumor pain relief—pointing toward safer, more personalized supportive cancer care. https://www.slas-technology.org/article/S2472-6303(25)00091-3/fulltext

PRIMDEx bridges the gap between 3D printing and injection molding, enabling faster, more affordable prototyping of microfluidic devices. Built for rapid design-test-build cycles, it removes key manufacturing bottlenecks in biotech R&D. https://ow.ly/jSvz50XXHvg

Lung cancer remains the leading cause of cancer deaths worldwide. This study shows how hybrid and ensemble machine learning models can integrate clinical and behavioral data to improve early risk prediction—supporting smarter screening and public health interventions. https://ow.ly/goAx50XXHtN

New Matter Podcast New Matter: Inside the Minds of SLAS Scientists is a podcast featuring people in the SLAS community of scientists, laboratory automation and technology providers, SLAS award winners and more

Podcast fans: New Matter is back! The latest episode features bite-sized previews with instructors from four of the #SLAS2026 Short Courses debuting this year in Boston. These snippets may be short on time, but long on programming details. https://www.slas.org/education/new-matter-podcast/

From Oregon State: A new high-throughput imaging platform is changing how we study zebrafish embryo behavior. With full-plate, high-resolution video capture & automated analysis, it removes key tech limits in early drug discovery & toxicology screening. https://ow.ly/1EWv50XXHkV

One of the most talked about areas of our conferences is the Innovation AveNEW for Startups, where companies showcase their drug discovery & lab advances through product demos by the scientists behind the innovations. Learn how to get involved in Vienna: https://ow.ly/wFyH50XWoJh.

In true Rizwan Chaudhrey fashion, he captured another info-packed preview of what’s to come at #SLAS2026. Watch the discussion to find out what attendees and exhibitors can look forward to, from this year’s educational tracks to the exhibition & beyond: https://www.youtube.com/watch?v=VnChByq7Bbk.

We're waltzing into 2026 with some key SLAS Europe Vienna deadline reminders. Learn more about how you can contribute your lab automation, drug discovery and screening research this May: https://ow.ly/LrvU50XSXK3

Find out the five finalists who will compete for the #SLAS2026 Student Poster Award: https://ow.ly/eTVZ50XS8Bl. While award opportunities have passed, it’s not too late to submit an abstract for the opportunity to present in Boston. Submit your research by Jan 19 to be considered.

Volume 37 of SLAS Discovery features the latest discoveries spanning topics such as pixel-wise channel isolation mixing, SARS-CoV-2 polymerase, PD-L1 expression changes in cancer cultures and other areas of drug discovery research: https://www.slas-discovery.org/current

Commit to empowering yourself in the new year by attending the Thrive in Science Women’s Leadership Forum at the conclusion of #SLAS2026, Feb 11-12. Learn practical strategies to strengthen your leadership skills and build meaningful connections: https://ow.ly/PYsu50XQIW2.

New HB-DBi-LSTM model + OCR + NLP boosts diagnostic accuracy from scanned EHRs (F1 ≈ 0.96, acc ≈ 0.93). By converting PDFs to structured data, it speeds sleep disorder detection + info extraction, improving hospital network efficiency + patient care. https://ow.ly/iUR550XP88z

New NICRP framework links diet to colorectal cancer risk using NLP + ATSO-LLMs. By analyzing food data & lifestyle patterns, it predicts CRC with ~98% accuracy and spotlights key nutritional factors for tailored prevention + care in diverse populations. https://ow.ly/fHAx50XP88y

Anaesthesia CareNet uses NLP (NER + GPT-3) + a fine-tuned IGE-LR model to predict pain needs & postop complications with ~91.7% accuracy. It personalizes anaesthesia plans and shows promise across diagnostics, drug discovery & precision medicine. https://ow.ly/RsKT50XP88r

New NLP + LLM framework predicts outcomes & complications in breast cancer reconstruction with ~98% accuracy. It personalizes recovery plans, forecasts risks and boosts patient & clinician decision-making for better quality of life. From June's SLAS Tech: https://ow.ly/CBzM50XP88k.

New AI for athlete heart health: A hybrid ML + RoBERTa NLP system spots arrhythmias & cardiomyopathies from ECGs, records & genetics with 92.5% accuracy. Smarter, earlier diagnoses + personalized treatment = safer sport. https://ow.ly/T5SO50XP88h

The final SLAS Technology volume of 2025 is now available. Volume 35 contains two reviews, two tech briefs, eight research articles, one protocol and excerpts from three Special Issues: https://www.slas-technology.org/current.